BJ BIO-TECH DEVELOPMENT MANAGEMENT GROUP HOLDING CORP.
OOTC:BJBJ0.30
USD
+0.05
(+20.52%)
ISIN
US98163R2067
CUSIP
98163R206
Return %
Stock
S&P 500
1Y
149,350.00
14.20
3Y
-71.26
81.12
5Y
49.45
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Daniel R. Mendes
- Full Time Employees
- 40
- Sector
- Industrial services
- Industry
- Engineering & construction
- Address
- 4004 NE Oshawa WA Canada 98056
- IPO Date
- Nov 17, 2009
- Website
- worryfreeholdings.com
- Similar Companies
- Business
- BJ Bio-Tech Development Management Group Holding Corp. operates as a biotechnology, healthcare, and health management holding company. The company engages in the research, development, manufacturing, processing, and marketing of biotechnology-derived wellness products, botanical formulations, and specialized health management solutions. Its primary product and service offerings include functional healthcare beverages, dietary and nutritional supplements, organic herbal and botanical extracts, therapeutic tea products, and wellness food items; biotechnology research and development consulting, intellectual property licensing, and technology transfer services; original equipment manufacturing (OEM) and original design manufacturing (ODM) for third-party nutritional brands; and integrated health management advisory, wellness consulting, and digital customer support services. The company serves individual consumers, retail distributors, healthcare centers, and corporate clients through direct sales networks, regional distributor partnerships, and online e-commerce platforms. In recent developments, BJ Bio-Tech Development Management Group Holding Corp. has executed strategic business reorganizations to expand its bio-agricultural and health technology operational footprint. The company has formed strategic distribution alliances and collaborative development partnerships with regional agricultural cooperatives and biotechnology research entities to enhance its supply chain integration and raw material sourcing. Additionally, it has launched modernized functional product lines, expanded its digital commerce infrastructure, and optimized its operational facilities to increase production efficiency and market penetration across East Asia and international markets. Founded in 2014, BJ Bio-Tech Development Management Group Holding Corp. is headquartered in Shenzhen, China, with corporate registration in the United States.